Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05233800 · ClinicalTrials.gov registry record · NA
mHealth for Breast Cancer Survivors With Insomnia
A NA study of Insomnia and Breast Cancer Survivor, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT05233800: Completed NA study of Insomnia and Breast Cancer Survivor, sponsored by Medstar Health Research Institute.
NCT05233800 is a NA study of Insomnia and Breast Cancer Survivor that has completed, run by Medstar Health Research Institute. The registered enrollment target is 76 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05233800, a NA study of Insomnia and Breast Cancer Survivor, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine the impact of the voice-activated smart speaker CBT-I components on insomnia symptoms among breast cancer survivors using a randomized clinical trial.
Primary Outcome
Data will be collected on the Insomnia Severity Index (ISI) total score pre- and post-intervention as our primary outcome. The ISI is a seven-item questionnaire with response categories from 0-4 (total score 0-28) asking about sleep patterns and specifically characterizing insomnia over the two weeks prior. The ISI defines 'no clinically significant' insomnia as a score of 0-7, 'sub-threshold' insomnia as a score of 8-14, 'moderate severity clinical' insomnia' a scores of 15-21, and 'severe clin
Conditions Studied
Interventions
- BEHAVIORAL Faster Asleep Smart Speaker Program
- BEHAVIORAL Faster Asleep Website
Study Locations (1)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2022-04-05 |
| Est. Completion | 2023-12-15 |
| Phase | NA |
What the finished NCT05233800 record still lists
NCT05233800 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (55% lower).
The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Faster Asleep Smart Speaker Program is the first listed.
NCT05233800 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05233800 about?
NCT05233800 is a clinical study titled "mHealth for Breast Cancer Survivors With Insomnia". The aim of this study is to determine the impact of the voice-activated smart speaker CBT-I components on insomnia symptoms among breast cancer survivors using a randomized clinical trial.
What is the current status of trial NCT05233800?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2022-04-05. Estimated completion is 2023-12-15.
What conditions does trial NCT05233800 study?
This clinical trial studies the following conditions: Insomnia, Breast Cancer Survivor.
What interventions are being tested in trial NCT05233800?
The interventions under investigation include: Faster Asleep Smart Speaker Program (BEHAVIORAL), Faster Asleep Website (BEHAVIORAL).
Who is sponsoring clinical trial NCT05233800?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05233800 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05233800's enrollment target sits among peer trials
76 81st of 151 higher than 70 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI